Go Life International Limited, a prominent pharmaceutical and healthcare company with listings on the Stock Exchange of Mauritius (SEM) and the AltX of the JSE, has announced a further extension of the deadline for releasing its financial results for the year ended 28th February 2023.
In a SENS announcement dated 14th June 2023, shareholders were initially informed that the abridged consolidated audited financial statements would be published by 15th July 2023. However, due to unforeseen delays in finalizing the audit process, the Company was unable to meet the deadline.
The Board of Directors of Go Life, which includes Executive Directors Patrick Wysoczanski and Jean van Rooyen, as well as Non-Executive Directors Mohamed Yusuf Sooklall and Peter Koll, expressed their responsibility for the accuracy of the information provided in the announcement.
To address the delay, Go Life International Limited applied to the Stock Exchange of Mauritius for an extension and has now received formal approval to release its abridged consolidated audited financial statements by 31st July 2023.
The Company’s shareholders, investors, and the market at large are eagerly anticipating the release of the financial results to gain insights into Go Life’s performance during the mentioned fiscal year. The extension has raised questions about the reasons behind the delays in finalizing the audit process.
The audit of a company’s financial statements is a crucial process that ensures accuracy, transparency, and compliance with accounting standards and regulations. Delays in finalizing the audit can occur due to various reasons, such as complex financial transactions, inadequate record-keeping, or the need for additional information and clarifications.
Go Life International Limited’s auditors are dedicated to completing the audit with utmost diligence to provide shareholders and investors with reliable financial information. The Company acknowledges the importance of releasing accurate and comprehensive financial results, as it directly impacts stakeholders’ decisions and confidence in the organization.
While the extension allows the Company to finalize the audit process diligently, it also underscores the significance of effective financial reporting and management procedures. Timely and accurate financial reporting is crucial for investors to assess the Company’s performance, financial health, and future prospects.
Go Life International Limited’s performance during the mentioned fiscal year may also be compared with industry peers to assess its competitive position and market share.
The Company’s JSE Sponsor, AcaciaCap Advisors Proprietary Limited, will play a crucial role in assisting Go Life throughout this extension period. The Sponsor’s expertise and support will help ensure compliance with listing rules and regulatory requirements.
As the revised deadline approaches, Go Life will diligently work towards finalizing its financial results for the year ended 28th February 2023. The Company remains committed to providing accurate and transparent financial information to its shareholders, investors, and the market.
Investors are advised to stay informed about any further updates from Go Life International Limited and monitor the Company’s website and official announcements from the Stock Exchange of Mauritius.
This website uses cookies.
